# Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

> clinical trial · VERIFIED · 2026-07-17

Status: ACTIVE_NOT_RECRUITING · Sponsor: Jonsson Comprehensive Cancer Center · Condition: Metastatic Malignant Female Reproductive System Neoplasm

- Company: Jonsson Comprehensive Cancer Center
- Sector: Metastatic Malignant Female Reproductive System Neoplasm
- Primary source: https://clinicaltrials.gov/study/NCT04395079

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.